Subscribe free

Newsletter

HPB & Spleen

Every new paper in this field, in your inbox.

FreeNo spamOne-click unsubscribe
Ann Surg14 Feb 2025

KRAS mutations in duodenal fluid improve pancreatic cancer detection

KRAS mutations identified in duodenal lavage fluid after secretin stimulation demonstrated a high diagnostic accuracy for detecting resectable pancreatic ductal adenocarcinoma (pdac). With an area Under the Curve (AUC) of 0.934, the method achieved a sensitivity of 83.1% at 100% specificity, significantly outperforming traditional serum…

Ann Surg Oncol14 Feb 2025

Dual-time-point radiomic models enhance prognosis prediction for colorectal liver metastasis

The dual-time-point radiomic models, developed using pre- and post-neoadjuvant therapy MRI features, effectively stratified colorectal liver metastasis patients undergoing surgery. In a study with 100 cases, post-neoadjuvant therapy models showed superior predictive power in overall and disease-free survival compared to pre-neoadjuvant therapy models. Fong score…

Ann Surg Oncol14 Feb 2025

AI framework quantifies clinical influences on posthepatectomy length of stay

An innovative artificial intelligence framework was developed to quantify the impact of clinical factors on posthepatectomy length of stay (LOS), explaining 75% of its variability. The study analyzed 21,039 patients, revealing that clinical influences are significant while nonclinical factors account for the remaining 25%. Notably,…

Eur J Med Res13 Feb 2025

Radiomics model predicts neoplastic gallbladder polyps accurately.

A new radiomics model utilizing contrast-enhanced ultrasound (CEUS) shows promising results for preoperative prediction of neoplastic gallbladder polyps over 10 mm. Analyzed data from 119 patients produced a logistic regression model that demonstrated an AUC of 0.95 in internal validation. This model enhances diagnostic precision,…

BMC Surg12 Feb 2025

Simultaneous curative resection enhances survival in colorectal liver metastases

A study involving 716 patients with colorectal liver metastases found that simultaneous curative resection significantly improves overall survival compared to palliative treatment. Curative resection emerged as an independent prognostic factor, with a hazard ratio of 1.95 indicating nearly double the survival benefit. The research also…

Ann Surg Oncol11 Feb 2025

Composite Endpoint of Liver Surgery Simplifies Clinical Trials

A novel Composite Endpoint of Liver Surgery (CELS) has been developed to enhance the feasibility of clinical trials in liver surgery by significantly reducing required sample sizes. Analyzing data from 1,958 patients, researchers found that 19.3% met CELS criteria, demonstrating strong predictive accuracy for surgery-related…

J Gastrointest Surg11 Feb 2025

Tumor marker clustering predicts hepatocellular carcinoma outcomes.

A multi-institutional study analyzed 1,515 hepatocellular carcinoma patients, revealing distinct prognostic clusters based on preoperative alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP) levels. Notably, patients with concurrent elevated AFP and DCP faced a 5-year overall survival rate of 52.8% and a recurrence rate of 79.3%. In…

HPB & Spleen9 Feb 2025

Combining radiofrequency ablation with immunotherapy improves HCC treatment outcomes

Combining radiofrequency ablation (RFA) with immunotherapy shows promising efficacy and manageable safety for hepatocellular carcinoma (HCC). It induces immunogenic substances and regulates immune cell responses, enhancing the anti-tumor immune effects and reconstructing the tumor microenvironment. This synergy reduces the risk of cancer recurrence and metastasis,…

Int J Surg8 Feb 2025

Non-enhanced abbreviated MRI outperforms contrast-enhanced CT for liver metastases detection

In a prospective study involving 587 colorectal cancer patients, non-enhanced abbreviated MRI (ne-amri) demonstrated superior diagnostic accuracy for liver metastases detection compared to contrast-enhanced CT (ce-ct). Across three surveillance rounds, ne-amri consistently showed higher lesion-based detection rates and better patient-based metrics, including sensitivity and specificity.…

J Gastrointest Cancer8 Feb 2025

Robotic pancreaticoduodenectomy shows improved outcomes over open surgery

A meta-analysis including 54,287 patients found robotic pancreaticoduodenectomy (RPD) significantly reduces overall postoperative complications, wound infections, estimated blood loss, and hospital stays compared to open pancreaticoduodenectomy (OPD). Although RPD resulted in longer operating times, it demonstrated a lower risk of complications overall. Both surgical approaches…